(IMCB) iShares Morningstar Mid-Cap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642882082

IMCB: Mid-Cap Stocks, Financial Securities

The iShares Morningstar Mid-Cap ETF (IMCB) is designed to track the performance of mid-capitalization U.S. stocks that exhibit a balance of growth and value characteristics, as defined by Morningstars proprietary methodology. By investing at least 80% of its assets in the component securities of its underlying index, the fund provides a diversified portfolio that captures the nuances of the mid-cap market segment.

The ETFs underlying index is constructed using Morningstars index methodology, which identifies mid-cap companies with a mix of growth and value attributes. This approach allows the fund to benefit from the potential upside of growth-oriented companies while maintaining a value investing discipline. As a result, IMCB offers a unique blend of investment characteristics that can help investors achieve a balanced portfolio.

Analyzing the , we observe that the ETFs price is currently above its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a positive short-term trend. The 200-day simple moving average (SMA200) is slightly below the current price, suggesting a potential area of resistance. The Average True Range (ATR) is relatively low, indicating moderate volatility. Considering these technical indicators, we can anticipate a potential price movement in the near term.

Combining the technical analysis with the , we note that the funds Assets Under Management (AUM) stand at approximately $1.066 billion USD. This sizable AUM indicates a reasonable level of investor interest and liquidity. By merging the technical and fundamental insights, we forecast that IMCB may experience a moderate price increase in the coming weeks, potentially reaching $80.00, driven by the ongoing trend and the funds underlying investment characteristics. However, investors should be cautious of potential volatility and monitor the ETFs price action relative to its moving averages and ATR.

Additional Sources for IMCB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IMCB ETF Overview

Market Cap in USD 1,062m
Category Mid-Cap Blend
TER 0.04%
IPO / Inception 2004-06-28

IMCB ETF Ratings

Growth Rating 62.2
Fundamental -
Dividend Rating 58.2
Rel. Strength -0.02
Analysts -
Fair Price Momentum 74.67 USD
Fair Price DCF -

IMCB Dividends

Dividend Yield 12m 1.16%
Yield on Cost 5y 2.12%
Annual Growth 5y 10.72%
Payout Consistency 97.1%
Payout Ratio %

IMCB Growth Ratios

Growth Correlation 3m 82.3%
Growth Correlation 12m 39.1%
Growth Correlation 5y 71.3%
CAGR 5y 13.15%
CAGR/Max DD 5y 0.52
Sharpe Ratio 12m 0.11
Alpha 0.88
Beta 0.895
Volatility 14.32%
Current Volume 20.1k
Average Volume 20d 16k
What is the price of IMCB shares?
As of June 26, 2025, the stock is trading at USD 78.13 with a total of 20,144 shares traded.
Over the past week, the price has changed by +1.09%, over one month by +1.37%, over three months by +3.63% and over the past year by +12.80%.
Is iShares Morningstar Mid-Cap a good stock to buy?
Yes. Based on ValueRay´s Analyses, iShares Morningstar Mid-Cap (NYSE ARCA:IMCB) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.21 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IMCB is around 74.67 USD . This means that IMCB is currently overvalued and has a potential downside of -4.43%.
Is IMCB a buy, sell or hold?
iShares Morningstar Mid-Cap has no consensus analysts rating.
What are the forecasts for IMCB share price target?
According to our own proprietary Forecast Model, IMCB iShares Morningstar Mid-Cap will be worth about 85.7 in June 2026. The stock is currently trading at 78.13. This means that the stock has a potential upside of +9.73%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 85.7 9.7%